BRPI0914069A2 - composição de vacina para uso contra o influenza - Google Patents
composição de vacina para uso contra o influenzaInfo
- Publication number
- BRPI0914069A2 BRPI0914069A2 BRPI0914069A BRPI0914069A BRPI0914069A2 BR PI0914069 A2 BRPI0914069 A2 BR PI0914069A2 BR PI0914069 A BRPI0914069 A BR PI0914069A BR PI0914069 A BRPI0914069 A BR PI0914069A BR PI0914069 A2 BRPI0914069 A2 BR PI0914069A2
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine composition
- against influenza
- use against
- influenza
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10366908P | 2008-10-08 | 2008-10-08 | |
PCT/EP2009/062894 WO2010040710A1 (en) | 2008-10-08 | 2009-10-05 | Vaccine composition for use against influenza |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0914069A2 true BRPI0914069A2 (pt) | 2016-09-27 |
Family
ID=41344771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0914069A BRPI0914069A2 (pt) | 2008-10-08 | 2009-10-05 | composição de vacina para uso contra o influenza |
Country Status (12)
Country | Link |
---|---|
US (1) | US9220767B2 (pt) |
EP (1) | EP2341931A1 (pt) |
JP (1) | JP5809560B2 (pt) |
CN (1) | CN102215864A (pt) |
AU (1) | AU2009301167B2 (pt) |
BR (1) | BRPI0914069A2 (pt) |
CA (1) | CA2739765A1 (pt) |
IL (1) | IL212200A (pt) |
MX (1) | MX338827B (pt) |
RU (1) | RU2571267C2 (pt) |
WO (1) | WO2010040710A1 (pt) |
ZA (1) | ZA201103175B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8916164B2 (en) | 2007-08-29 | 2014-12-23 | Abivax | Methods of enhancing adjuvaticity of vaccine compositions |
KR101566847B1 (ko) | 2007-12-05 | 2015-11-06 | 아비박스 | 항원에 대한 면역 반응 증강을 위한 글리코실세라마이드의 용도 |
US9220767B2 (en) * | 2008-10-08 | 2015-12-29 | Abivax | Vaccine composition for use against influenza |
KR20140027987A (ko) * | 2011-04-08 | 2014-03-07 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 인플루엔자 바이러스 복제를 억제하는 방법 및 약학조성물 |
GB201205189D0 (en) * | 2012-03-23 | 2012-05-09 | Glaxosmithkline Biolog Sa | Novel medical use |
WO2013162016A1 (ja) | 2012-04-26 | 2013-10-31 | 独立行政法人理化学研究所 | 新規カルバメート糖脂質およびその用途 |
CA2880191C (en) * | 2012-07-26 | 2021-04-20 | Callaghan Innovation Research Limited | Sphingoglycolipid analogues as therapeutic agents |
US10086054B2 (en) * | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
CA3036598A1 (en) * | 2016-09-14 | 2018-03-22 | Abivax | Combinations including abx196 for the treatment of cancer |
CN111182907B (zh) * | 2017-09-13 | 2023-01-06 | Abivax公司 | 用于治疗膀胱癌的abx196 |
JP7304863B2 (ja) | 2017-12-29 | 2023-07-07 | グリコミメティクス, インコーポレイテッド | E-セレクチンおよびガレクチン-3のヘテロ二機能性阻害剤 |
KR20210110645A (ko) | 2018-12-27 | 2021-09-08 | 글리코미메틱스, 인크. | 갈렉틴-3 억제 c-글리코사이드 |
US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
WO2023121483A1 (en) * | 2021-12-24 | 2023-06-29 | Victoria Link Limited | Immunostimulatory compositions |
CN115286667B (zh) * | 2022-08-02 | 2024-03-26 | 华中农业大学 | 一种α-半乳糖基神经酰胺类似物及其制备方法和应用 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1592453A (en) * | 1976-05-14 | 1981-07-08 | Smith Kline French Lab | Aminoalkyl esters of carbarimidothioic acid and compositions having immunosuppressant activity |
US5242800A (en) * | 1990-01-30 | 1993-09-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Receptor for pathogenic fungi |
US5936076A (en) * | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
TW261533B (pt) * | 1992-07-16 | 1995-11-01 | Kirin Brewery | |
JP3717512B2 (ja) * | 1992-10-22 | 2005-11-16 | 麒麟麦酒株式会社 | 新規スフィンゴ糖脂質およびその使用 |
US5780441A (en) * | 1993-04-15 | 1998-07-14 | Kirin Beer Kabushiki Kaisha | Sphingoglycolipid compounds and therapeutic uses thereof |
CN1125449A (zh) * | 1993-05-14 | 1996-06-26 | 萨依特尔有限公司 | 作为细胞粘附抑制剂的唾液基Lex类似物 |
US6054433A (en) * | 1994-11-03 | 2000-04-25 | The Regents Of The University Of California | Methods and compositions for stimulating tissue growth and epithelial moisturization |
US5785975A (en) * | 1995-06-26 | 1998-07-28 | Research Triangle Pharmaceuticals | Adjuvant compositions and vaccine formulations comprising same |
EP0821068A3 (en) * | 1996-03-29 | 1999-06-02 | Rohm And Haas Company | Novel sphingolipids and a process thereto |
ATE268180T1 (de) | 1997-02-05 | 2004-06-15 | Kirin Brewery | Glycosphingolipide enthaltende gefriergetrocknete zusammensetzung |
US6417167B1 (en) * | 1997-02-05 | 2002-07-09 | Kirin Beer Kabushiki Kaisha | Lyophilized compositions containing shingoglycolipid and process for preparing them |
CN1768759A (zh) | 1997-04-10 | 2006-05-10 | 麒麟麦酒株式会社 | 神经酰胺化合物在制备细胞活化剂中的应用 |
AU750141B2 (en) | 1997-12-30 | 2002-07-11 | A+ Science Invest Ab | Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
CA2320117A1 (en) * | 1998-02-12 | 1999-08-19 | Emory University | Sphingolipid derivatives and their methods of use |
US20030157113A1 (en) * | 1999-12-28 | 2003-08-21 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
AU2001252599A1 (en) * | 2000-04-28 | 2001-11-12 | Orient Cancer Therapy Co., Ltd. | Remedies for cancer |
JP4410913B2 (ja) * | 2000-06-12 | 2010-02-10 | 壽製薬株式会社 | 新規糖脂質誘導体の製造方法 |
US20020115624A1 (en) * | 2000-06-22 | 2002-08-22 | Behar Samuel M. | Alpha gylcosylceramides for treating bacterial and fungal infections |
WO2002018539A2 (en) * | 2000-08-25 | 2002-03-07 | Lysometrix Corporation | Method for assaying the activity of lysosomal enzymes |
AU2002327338A1 (en) * | 2001-07-25 | 2003-02-17 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
KR100549866B1 (ko) | 2001-08-22 | 2006-02-08 | 고려대학교 산학협력단 | 암치료 및 예방 제제 |
CN1578667A (zh) * | 2001-11-06 | 2005-02-09 | 东方癌症治疗株式会社 | 抗癌组合物 |
US7273853B2 (en) * | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
JP2005533057A (ja) * | 2002-06-13 | 2005-11-04 | ニューヨーク・ユニバーシティ | 合成c−糖脂質、ならびに癌、感染性疾患および自己免疫疾患を処置するための合成c−糖脂質の使用 |
CA2519568C (en) | 2003-03-20 | 2012-01-03 | Brigham Young University | 6"-amino-6"-deoxygalactosylceramides |
US7645873B2 (en) * | 2003-03-20 | 2010-01-12 | The Scripps Research Institute | 6″-amino-6″-deoxygalactosylceramides |
GB0314682D0 (en) | 2003-06-24 | 2003-07-30 | Isis Innovation | Materials and methods relating to the modulation of T cell response to soluble antigen |
US7771726B2 (en) * | 2003-10-08 | 2010-08-10 | New York University | Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases |
CA2560969A1 (en) | 2004-03-31 | 2005-11-03 | New York University | Novel synthetic c-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases |
EP1784196B1 (en) | 2004-08-27 | 2016-12-21 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
US7998739B2 (en) * | 2004-09-03 | 2011-08-16 | The Scipps Research Institute | Methods of activating NKT cells |
AU2005322027B2 (en) * | 2004-12-28 | 2013-09-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NK Tcells |
EP1848813B1 (en) | 2005-01-28 | 2013-04-10 | Brigham Young University | Bacterial glycolipid activation of cd1d-restricted nkt cells |
KR100764678B1 (ko) * | 2005-07-13 | 2007-10-09 | 재단법인서울대학교산학협력재단 | 알파-갈락토실세라마이드를 아쥬반트로 포함하는 비강투여용 백신 조성물 |
CA2626997C (en) | 2005-10-25 | 2014-12-23 | Ludwig Institute For Cancer Research | Analogs of alpha galactosylceramide and uses thereof |
CA2661789C (en) * | 2006-04-07 | 2014-06-03 | The Scripps Research Institute | Modified .alpha.-galactosyl ceramides for staining and stimulating natural killer t cells |
CN101426523B (zh) * | 2006-04-27 | 2013-03-27 | 财团法人首尔大学校产学协力财团 | 基于负载了天然杀伤t细胞的配体、和抗原的b细胞的疫苗 |
US7794722B2 (en) * | 2006-06-30 | 2010-09-14 | The Scripps Research Institute | Adjuvants and methods of use |
EP1938836A1 (en) | 2006-12-28 | 2008-07-02 | Universite Rene Descartes (Paris V) | Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells |
KR100868959B1 (ko) * | 2006-12-30 | 2008-11-17 | 재단법인서울대학교산학협력재단 | 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물 |
US9220767B2 (en) * | 2008-10-08 | 2015-12-29 | Abivax | Vaccine composition for use against influenza |
-
2009
- 2009-10-05 US US13/123,122 patent/US9220767B2/en not_active Expired - Fee Related
- 2009-10-05 JP JP2011530464A patent/JP5809560B2/ja not_active Expired - Fee Related
- 2009-10-05 WO PCT/EP2009/062894 patent/WO2010040710A1/en active Application Filing
- 2009-10-05 CA CA2739765A patent/CA2739765A1/en not_active Abandoned
- 2009-10-05 RU RU2011117167/15A patent/RU2571267C2/ru not_active IP Right Cessation
- 2009-10-05 BR BRPI0914069A patent/BRPI0914069A2/pt not_active IP Right Cessation
- 2009-10-05 EP EP09783735A patent/EP2341931A1/en not_active Ceased
- 2009-10-05 MX MX2011003756A patent/MX338827B/es active IP Right Grant
- 2009-10-05 AU AU2009301167A patent/AU2009301167B2/en not_active Ceased
- 2009-10-05 CN CN2009801433835A patent/CN102215864A/zh active Pending
-
2011
- 2011-04-07 IL IL212200A patent/IL212200A/en not_active IP Right Cessation
- 2011-04-29 ZA ZA2011/03175A patent/ZA201103175B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2739765A1 (en) | 2010-04-15 |
US20110229519A1 (en) | 2011-09-22 |
AU2009301167A1 (en) | 2010-04-15 |
IL212200A (en) | 2015-08-31 |
CN102215864A (zh) | 2011-10-12 |
JP5809560B2 (ja) | 2015-11-11 |
MX338827B (es) | 2016-05-03 |
MX2011003756A (es) | 2011-09-06 |
JP2012505174A (ja) | 2012-03-01 |
ZA201103175B (en) | 2012-01-25 |
AU2009301167B2 (en) | 2015-10-29 |
US9220767B2 (en) | 2015-12-29 |
RU2011117167A (ru) | 2012-11-20 |
RU2571267C2 (ru) | 2015-12-20 |
IL212200A0 (en) | 2011-06-30 |
EP2341931A1 (en) | 2011-07-13 |
WO2010040710A1 (en) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0914069A2 (pt) | composição de vacina para uso contra o influenza | |
BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BR112014001255A2 (pt) | composto, uso de um composto, combinação, e, composição farmacêutica | |
BRPI0911297A2 (pt) | composição e métodos para preparo e uso das mesmas | |
BRPI0811979A2 (pt) | Formulação para vacinas de meningite | |
BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
BRPI0920240A2 (pt) | formulação de adjuvante de combinação | |
BRPI1005670A8 (pt) | composições adjuvantes e processos de uso. | |
ITMI20080003A1 (it) | Composizioni per uso oftalmico | |
BRPI0923513A2 (pt) | método e composições para uso de uma vacina de coccidiose | |
BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0919165A2 (pt) | composição farmacêutica,e, uso de um composto | |
BRPI0915473A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921935A2 (pt) | composições adesivas de uso médico | |
BRPI1007186A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0918517A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BR112012031967A2 (pt) | composto, uso de um composto, combinação de um composto e composição farmacêutica | |
BRPI1013597A2 (pt) | seringa para uso único | |
BRPI0913986A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0909840A2 (pt) | Uso de 4-tio-2-deoxinucleosídios |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: VINCENT SERRA (FR) , ABIVAX (FR) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |